questionsmedicales.fr
Cellules
Neurones
Neurofibres
Neurofibres cholinergiques
Neurofibres parasympathiques postganglionnaires
Neurofibres parasympathiques postganglionnaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Dysfonction parasympathique
Tests neurologiques
Électromyographie
Imagerie par résonance magnétique
Sécheresse buccale
Troubles de la digestion
Tests sanguins
Inflammation
Fonction parasympathique
Réponse pupillaire
Symptômes
5
Sécheresse buccale
Constipation
Dysautonomie
Palpitations
Troubles de la sudation
Dysfonction parasympathique
Atteinte nerveuse
Engourdissements
Troubles de la miction
Dysfonction parasympathique
Prévention
5
Prévention
Gestion du stress
Exercice régulier
Système nerveux
Alimentation saine
Santé nerveuse
Contrôle du stress
Symptômes
Bilans de santé
Détection précoce
Traitements
5
Médicaments
Thérapie physique
Médicaments anticholinergiques
Dysfonction
Thérapie comportementale
Qualité de vie
Interventions chirurgicales
Dysfonction
Changements de mode de vie
Alimentation équilibrée
Complications
5
Complications
Troubles digestifs
Troubles de la vision
Atteinte nerveuse
Problèmes de miction
Traitement
Infections urinaires
Dysfonction
Circulation sanguine
Dysfonction nerveuse
Facteurs de risque
5
Stress chronique
Système nerveux
Maladies auto-immunes
Neurofibres
Hérédité
Troubles nerveux
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres parasympathiques postganglionnaires : Questions médicales les plus fréquentes",
"headline": "Neurofibres parasympathiques postganglionnaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres parasympathiques postganglionnaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-08",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurofibres cholinergiques",
"url": "https://questionsmedicales.fr/mesh/D002799",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres cholinergiques",
"code": {
"@type": "MedicalCode",
"code": "D002799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires",
"alternateName": "Parasympathetic Fibers, Postganglionic",
"code": {
"@type": "MedicalCode",
"code": "D017777",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rachel M Fenning",
"url": "https://questionsmedicales.fr/author/Rachel%20M%20Fenning",
"affiliation": {
"@type": "Organization",
"name": "Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA."
}
},
{
"@type": "Person",
"name": "Stephen A Erath",
"url": "https://questionsmedicales.fr/author/Stephen%20A%20Erath",
"affiliation": {
"@type": "Organization",
"name": "College of Human Sciences, Auburn University, Auburn, Alabama, USA."
}
},
{
"@type": "Person",
"name": "Jason K Baker",
"url": "https://questionsmedicales.fr/author/Jason%20K%20Baker",
"affiliation": {
"@type": "Organization",
"name": "Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA."
}
},
{
"@type": "Person",
"name": "Frances Rucker",
"url": "https://questionsmedicales.fr/author/Frances%20Rucker",
"affiliation": {
"@type": "Organization",
"name": "New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA. Electronic address: ruckerf@neco.edu."
}
},
{
"@type": "Person",
"name": "Chris Taylor",
"url": "https://questionsmedicales.fr/author/Chris%20Taylor",
"affiliation": {
"@type": "Organization",
"name": "New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Depression circuit adaptation in post-stroke depression.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37201899",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.05.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dissecting the depressed mood criterion in adult depression: The heterogeneity of mood disturbances in major depressive episodes.",
"datePublished": "2022-11-28",
"url": "https://questionsmedicales.fr/article/36455714",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2022.11.047"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rethinking treatment-resistant depression to quasi-tenacious depression.",
"datePublished": "2023-01-12",
"url": "https://questionsmedicales.fr/article/36632817",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/j.eurpsy.2022.2353"
}
},
{
"@type": "ScholarlyArticle",
"name": "Viewpoint: Difficult-to-treat depression versus treatment-resistant depression: A new integrative perspective for managing depression.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37680180",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/j.eurpsy.2023.2448"
}
},
{
"@type": "ScholarlyArticle",
"name": "Innate depression.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35998233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1126/scisignal.ade4885"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres",
"item": "https://questionsmedicales.fr/mesh/D009412"
},
{
"@type": "ListItem",
"position": 5,
"name": "Neurofibres cholinergiques",
"item": "https://questionsmedicales.fr/mesh/D002799"
},
{
"@type": "ListItem",
"position": 6,
"name": "Neurofibres parasympathiques postganglionnaires",
"item": "https://questionsmedicales.fr/mesh/D017777"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres parasympathiques postganglionnaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres parasympathiques postganglionnaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres parasympathiques postganglionnaires",
"description": "Comment diagnostiquer une dysfonction parasympathique ?\nQuels examens sont utilisés pour évaluer les neurofibres ?\nQuels symptômes nécessitent un diagnostic ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?\nComment évaluer la fonction parasympathique ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Depression#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres parasympathiques postganglionnaires",
"description": "Quels sont les symptômes d'une atteinte parasympathique ?\nComment se manifeste une dysautonomie ?\nLes troubles de la sudation sont-ils liés ?\nQuels signes indiquent une atteinte nerveuse ?\nLes troubles de la miction sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Depression#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres parasympathiques postganglionnaires",
"description": "Peut-on prévenir les troubles parasympathiques ?\nL'exercice régulier aide-t-il à prévenir ?\nUne alimentation saine est-elle bénéfique ?\nLe contrôle du stress est-il important ?\nLes bilans de santé réguliers sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Depression#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres parasympathiques postganglionnaires",
"description": "Quels traitements sont disponibles pour la dysfonction ?\nLes médicaments anticholinergiques sont-ils utilisés ?\nLa thérapie comportementale est-elle efficace ?\nDes interventions chirurgicales sont-elles possibles ?\nComment les changements de mode de vie aident-ils ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Depression#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres parasympathiques postganglionnaires",
"description": "Quelles complications peuvent survenir ?\nLes troubles de la vision sont-ils une complication ?\nDes problèmes de miction peuvent-ils s'aggraver ?\nLes infections urinaires sont-elles fréquentes ?\nLes troubles de la circulation sanguine sont-ils possibles ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Depression#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres parasympathiques postganglionnaires",
"description": "Quels facteurs augmentent le risque de dysfonction ?\nLe stress chronique est-il un facteur de risque ?\nLes maladies auto-immunes sont-elles un risque ?\nL'obésité influence-t-elle le risque ?\nL'hérédité joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Depression#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction parasympathique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut inclure des tests neurologiques et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les neurofibres ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électromyographie et l'imagerie par résonance magnétique sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la sécheresse buccale ou des troubles de la digestion peuvent alerter."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à évaluer des marqueurs d'inflammation ou d'autres anomalies."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction parasympathique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de réponse pupillaire et de fréquence cardiaque peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une atteinte parasympathique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la sécheresse buccale, la constipation et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une dysautonomie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des vertiges, des palpitations et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Les troubles de la sudation sont-ils liés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction parasympathique peut entraîner des anomalies de la sudation."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une atteinte nerveuse ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des engourdissements ou des douleurs peuvent indiquer une atteinte."
}
},
{
"@type": "Question",
"name": "Les troubles de la miction sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes de miction peuvent survenir en raison d'une dysfonction parasympathique."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles parasympathiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures préventives incluent un mode de vie sain et la gestion du stress."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à prévenir ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut renforcer le système nerveux et prévenir des troubles."
}
},
{
"@type": "Question",
"name": "Une alimentation saine est-elle bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments peut soutenir la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes, donc le contrôle est essentiel."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers sont-ils recommandés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent aider à détecter précocement des problèmes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la dysfonction ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, la thérapie physique et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Les médicaments anticholinergiques sont-ils utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être prescrits pour traiter certains symptômes de dysfonction."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle efficace ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à gérer les symptômes et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Des interventions chirurgicales sont-elles possibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des interventions chirurgicales peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Comment les changements de mode de vie aident-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et l'exercice régulier peuvent améliorer les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles digestifs sévères et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision sont-ils une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la vision peuvent survenir en raison d'une atteinte nerveuse."
}
},
{
"@type": "Question",
"name": "Des problèmes de miction peuvent-ils s'aggraver ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les problèmes de miction peuvent devenir plus graves."
}
},
{
"@type": "Question",
"name": "Les infections urinaires sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent survenir en raison de troubles de la miction liés à la dysfonction."
}
},
{
"@type": "Question",
"name": "Les troubles de la circulation sanguine sont-ils possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la circulation peuvent survenir en raison d'une dysfonction nerveuse."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dysfonction ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le diabète, l'hypertension et l'âge avancé augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à la dysfonction du système nerveux."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter les neurofibres parasympathiques."
}
},
{
"@type": "Question",
"name": "L'obésité influence-t-elle le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité peut augmenter le risque de troubles nerveux et de dysfonction."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles nerveux peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA.
Department of Psychological Science and The Claremont Autism Center, Claremont McKenna College, Claremont, California, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
3 publications dans cette catégorie
Affiliations :
College of Human Sciences, Auburn University, Auburn, Alabama, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
3 publications dans cette catégorie
Affiliations :
Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA. Electronic address: ruckerf@neco.edu.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Center for Anatomy and Cell Biology, Institute of Anatomy and Cell Biology - Salzburg Paracelsus Medical University, Salzburg, Austria.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Center for Anatomy and Cell Biology, Institute of Anatomy and Cell Biology - Salzburg Paracelsus Medical University, Salzburg, Austria.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Psychological Science, University of California, Irvine, Irvine, CA, United States.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
ULR 2694- METRICS: Evaluation des technologies de santé et des pratiques médicales, University of Lille, 59000, Lille, France.
CHU Lille, Department of Neonatology, Jeanne de Flandre Hospital, 59000, Lille, France.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
ULR 2694- METRICS: Evaluation des technologies de santé et des pratiques médicales, University of Lille, 59000, Lille, France.
CHU Lille, CIC-IT 1403, Centre D'Innovation Technologique, 59000, Lille, France.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Osaka University, Osaka, Japan.
Graduate School of Frontiers Bioscience, Osaka University, Osaka, Japan.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Department of Cell Biology, University of Virginia, Charlottesville, Virginia. Electronic address: kld5u@virginia.edu.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia. mpm@ysmu.ru.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
Lesion locations of post-stroke depression (PSD) mapped to a depression circuit which centered by the left dorsolateral prefrontal cortex (DLPFC). However, it remains unknown whether the compensatory ...
Rs-fMRI data were collected from 82 non-depressed stroke patients (Stroke), 39 PSD patients and 74 healthy controls (HC). We tested the existence of depression circuit, examined PSD-related alteration...
We found that: 1) the left DLPFC showed significantly stronger connectivity to lesions of PSD than Stroke group; 2) in comparison to both Stroke and HC groups, PSD exhibited increased connectivity wit...
Longitudinal studies are required to explore the alterations of depression circuit in PSD as the disease progress....
PSD underwent specific alterations in depression circuit, which may help to establish objective imaging markers for early diagnosis and interventions of the disease....
Mood disturbances have historically remained a core criterion in diagnosing major depressive episode. DSMs have illustrated this criterion with depressed, hopeless, discouraged, cheerless, and irritab...
The current study used a nationally representative sample of U.S. adults with unipolar major depressive disorder to study the association between specific forms of mood disturbances to depression seve...
Cheerless and hopeless mood were associated with depression severity. Hopeless and irritable mood were associated with depression chronicity. Different forms of mood disturbance showed differential re...
The relations between different forms of mood disturbances and various aspects of depression are nuanced. Theoretically, these relations highlight the potential utility in acknowledging the complexity...
With almost one-third of patients with major depression not adequately responsive to treatments, the management of treatment-resistant depression (TRD) has continued to be challenging. Recently, an es...
In the STAR*D study, the efficacy of treatments for major depression was examined. It was found that, while many responded to the initial antidepressant treatment, only 30% of participants achieved co...
Restoring AHI1 in macrophages may improve antiviral immunity in patients with depression....
Depressive disorders encompass a spectrum of diagnoses and are more common in women and transgender individuals. Diagnosis involves thorough history-taking and exclusion of underlying medical disorder...
To review and summarize the literature published between 1 January 2020 and 30 June 2022, on the prevalence, risk factors and impact of depression in transplant population....
Depression is common in transplantation candidates and recipients, with a prevalence up to 85.8% in kidney recipients. Multiple studies have indicated after transplantation depression correlates with ...
Depression is a common finding in transplant population. More research is needed to understand the biological substrate and risk factors and to develop effective treatment interventions....
The goal of this study was to explore the coping strategies of depression sufferers that have worked for them based on the study of an online depression community....
We conducted a thematic narrative analysis of 120 stories posted by the members in the largest online depression community in China. MaxQDA version 18 was used to code the data, and the analytic appro...
The study found that the coping strategies mainly include self-reconciliation (e.g., perceiving/accepting feelings, accepting the present self, and holding hope for the future), actions (recreational ...
The findings revealed the coping strategies that were helpful and examined how they functioned for the affected members, which make up for the lack of attention to the individual experiences of depres...
Evidence-based treatments for adult depression include psychotherapy and pharmacotherapy, yet little is known about how baseline depression severity moderates treatment outcome....
We aimed to compare the effects of psychotherapy and pharmacotherapy for adult depression and to examine the association between baseline depression severity and treatment outcome, converting multiple...
We conducted systematic searches in bibliographical databases up to September 2022 to identify randomized controlled trials (RCTs) in which psychotherapy was compared with pharmacotherapy in the treat...
We identified 65 RCTs including 7250 participants for the meta-analyses and 56 RCTs including 5548 participants for the meta-regression. We found no significant difference between psychotherapy and ph...
Limitations included the low quality of the included studies, and the omission of long-term effects and within-study variability....
We found no indication for a moderation effect of baseline depression severity on the relative effects of psychotherapy and pharmacotherapy. Thus, other factors such as availability and patients' pref...
Depression is a leading cause of disability, affecting approximately 300 million people globally [...]....